Thaçi D, Vender R, de Rie M, Conrad C, Soung J, Strober B, Wang M, Cross N, Deherder D, Gomez NN, Gottlieb AB. Bimekizumab efficacy and safety through three years in patients with moderate to severe plaque psoriasis: Long-term results from the BE SURE randomized controlled trial and the BE BRIGHT open-label extension. J of Skin [Internet]. 2022 Nov. 16 [cited 2024 Jul. 22];6(6):s68. Available from: https://jofskin.org/33014/index.php/skin/article/view/1824